• English
  • 简体中文
Login Register
Current Location: Home > CFDA Approvals(Domestic) Feedback Help
Latest Data
-
-
-
Historical Data
-
-
-
-
-
Export
Drug Name Active Ingredient Dosage Form Strength Manufacturers Manufacturers Approval No. Same Variety(Same Strength) Approval Date Drug Classification Details
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位(笔芯) 江苏万邦生化医药集团有限责任公司 Wanbang Biopharmaceuticals 国药准字S20220027 view 2022-08-30 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位(笔芯) 珠海联邦制药股份有限公司 Zhuhai United Laboratories Co Ltd 国药准字S20160009 view 2021-11-04 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位(笔芯) 山东新时代药业有限公司 Shandong New Time Pharmaceutical Co Ltd 国药准字S20220016 view 2022-05-10 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位/预填充 通化东宝药业股份有限公司 Tonghua Dongbao Pharmaceutical Co Ltd 国药准字S20217020 view 2021-08-13 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 10ml:1000单位/支 通化东宝药业股份有限公司 Tonghua Dongbao Pharmaceutical Co Ltd 国药准字S20190042 view 2019-12-06 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位/支 通化东宝药业股份有限公司 Tonghua Dongbao Pharmaceutical Co Ltd 国药准字S20190041 view 2019-12-06 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位/支(笔芯) 宜昌东阳光长江药业股份有限公司 Yichang Hec Changjiang Pharmaceutical Co Ltd 国药准字S20210042 view 2021-10-26 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位/笔芯 赛诺菲(北京)制药有限公司 Sanofi (Beijing) Pharmaceuticals Co Ltd 国药准字S20201000 view 2020-02-05 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位/预填充SoloStar 赛诺菲(北京)制药有限公司 Sanofi (Beijing) Pharmaceuticals Co Ltd 国药准字S20201001 view 2020-02-05 Medicare(class B) view
甘精胰岛素注射液 insulin glargine Injection 3ml:300单位(预填充) 珠海联邦制药股份有限公司 Zhuhai United Laboratories Co Ltd 国药准字S20173001 view 2021-11-04 Medicare(class B) view